Skip to content
Dx

ICD-10-CM 2027 diagnosis code

R97.2Elevated prostate specific antigen [PSA]

Not billable — use a more specific code

R97.2 is a header code, so it can't be reported by itself. Choose one of the 2 more specific codes beneath it.

Code last changed in FY2017 (effective October 1, 2016). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About R97.2

R97.2 is the ICD-10-CM diagnosis code for elevated prostate specific antigen [PSA]. It belongs to category R97 (abnormal tumor markers), block R97 (abnormal tumor markers) and chapter 18 (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified). It is a header code, so it can't be reported by itself; one of its 2 subcodes must be used instead.

Within R97 (abnormal tumor markers), R97.2 is specifically for elevated prostate specific antigen [PSA]. Related codes cover elevated carcinoembryonic antigen [CEA] (R97.0), elevated cancer antigen 125 [CA 125] (R97.1) and other abnormal tumor markers (R97.8).

To report this condition, pick the subcode that matches the documentation: R97.20 ([PSA]) and R97.21 (prostate).

It has been part of ICD-10-CM since the code set took effect on October 1, 2015, and changed in FY2017 (expanded into subcodes).

Specific codes under R97.2

Notes that apply from higher levels

Instructions written at a parent level also apply to R97.2.

Broader instructions also apply from Chapter 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • FY2017 (effective 10/1/2016): Expanded — no longer billable

Common questions about R97.2

Is R97.2 billable?

No. R97.2 is a header code. Report one of its more specific subcodes instead.